Mylan ‘Likely To Win’ On US Tecfidera Challenge

Verdict In Litigation Is Expected By 20 June

Gavels
Mylan is aiming to topple the sole Tecfidera patent in its path • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin